.png)
Analyzed data points: 6,613
Specialties: Oncologists, Hematologists, Pathologists
Countries analyzed: 71
Reach: 80,432
Main Points Concerning AML Diagnosis, Treatment, and Follow-up:
AML Diagnosis
Diagnostic Techniques: Posts mention the use of various diagnostic methods, including bone marrow biopsies and subtyping with specific antigen tests like CD7.
Patient Symptoms and Initial Diagnosis: Physicians discuss initial symptoms leading to the diagnosis, such as fatigue, anemia, or suspicious blood counts.
AML Treatment
Chemotherapy and Medication: The primary treatment discussed is chemotherapy, including specific queries on drugs like Azacitidine, when first line therapies have failed.
Long-term Therapy: Discussions about maintenance treatments to prevent relapse, such as using Azacitidine for maintenance.
AML Follow-up
Monitoring and Recurrence: Regular follow-up visits and tests are essential to monitor remission status and detect any recurrence early.
Post-treatment Care: Follow-up care includes managing long-term side effects of treatments and ensuring overall physical and psychological health.
Examples of Concerns of G-Med Physicians on the Topic of AML:
Child Growth after Bisphosphonate Therapy and Chemotherapy:
Concern: The impact of Zolendronate and chemotherapy on child growth.
Insight: Physicians are interested in the long-term effects of treatments on pediatric patients, specifically focusing on growth and development post-therapy.
Persistent Hiccups in a 60-year-old AML Patient:
Concern: Managing unusual symptoms like persistent hiccups in AML patients.
Insight: There is a need for discussing and finding solutions to rare but troublesome symptoms that affect the quality of life in AML patients.
Aberrant Expression of CD7 Antigen in AML:
Concern: The significance of CD7 antigen expression in AML cases.
Insight: There is an active interest in understanding the molecular and immunological characteristics of AML, and its significance on subtyping and treatment strategies.
These posts reflect a broad range of concerns, including the impact of treatments on different age groups, management of rare symptoms, staying updated with international research, and understanding molecular characteristics of AML.
Geographical Differences in Physicians’ AML Concerns:
North America
Innovative Treatments: Focus on advanced treatment options like CAR-T cell therapy.
Europe
Pediatric Leukemia: Concern about pediatric leukemias with mentions of specific studies and case reports.
Treatment Protocols: Focus on chemotherapy regimens and their effectiveness.
Asia
Pediatric Leukemia Studies: Similar to Europe, there is a significant focus on pediatric leukemias and related studies.
Case Studies: Detailed case studies of specific patients, focusing on diagnosis and treatment paths.
Middle East
Local Treatment Challenges: Discussions on regional challenges and treatment protocols specific to the Middle East.
Africa
Ethical and Intellectual Challenges: Emphasis on the intellectual and scientific challenges in treating AML, with a focus on health equity.
These insights can help tailor communication and support strategies for physicians in different regions, addressing their specific concerns and focal points more effectively.
Engagement Recommendations:
As can be seen from the report, there are some clear knowledge gaps on the topic of AML which could be closed by an awareness campaign.
G-Med's Awareness Package could be a good fit here.
